Home > Healthcare > Biotechnology > Biopharma > Protein Engineering Market

Protein Engineering Market Trends

Report ID: GMI8008
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Protein Engineering Market Trends

The increasing number of government initiatives is driving technological advancements. Governments are actively funding R&D projects for tackling protein-deficient disorders. Scientists are collaborating with policymakers to create innovative protein-based therapies and preventive measures. Moreover, government support will continue to propel the market growth for fostering the creation of more effective and accessible treatments for malnutrition-related diseases. This concerted effort will underscore the commitment to improving global health outcomes and addressing the root causes of protein deficiency.

For instance, the Japanese government's AI research initiative is boosting advancements in biopharmaceuticals, such as RevolKa, a biotech start-up that leverages machine learning to expedite protein engineering.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Protein engineering market size was over USD 2.5 billion in 2023 and is expected to register 15.9% CAGR from 2024-2032 owing to the growing collaborations and partnerships for fostering innovations and advancements in the field, worldwide.

Protein engineering industry from the reagents segment is expected to register 16.2% CAGR from 2024-2032 due to playing a crucial role in protein engineering, with researchers continuously refining and developing new ones.

North America protein engineering industry is expected to reach over USD 3.75 billion by 2032 due to notable shift towards sustainable and green technologies in the region.

Amgen Inc., Bruker Corporation, Danaher Corporation, Genentech, Inc., Integrated DNA Technologies, Inc., Lonza Group, Merck KGaA, Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Incorporated, are some of the major protein engineering companies worldwide.